These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22389315)

  • 1. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
    Vieira AF; Ricardo S; Ablett MP; Dionísio MR; Mendes N; Albergaria A; Farnie G; Gerhard R; Cameselle-Teijeiro JF; Seruca R; Schmitt F; Clarke RB; Paredes J
    Stem Cells; 2012 May; 30(5):854-64. PubMed ID: 22389315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
    Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
    BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
    Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions.
    Li Q; Eades G; Yao Y; Zhang Y; Zhou Q
    J Biol Chem; 2014 Jan; 289(3):1303-12. PubMed ID: 24297178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.
    To K; Fotovati A; Reipas KM; Law JH; Hu K; Wang J; Astanehe A; Davies AH; Lee L; Stratford AL; Raouf A; Johnson P; Berquin IM; Royer HD; Eaves CJ; Dunn SE
    Cancer Res; 2010 Apr; 70(7):2840-51. PubMed ID: 20332234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
    Bane A; Viloria-Petit A; Pinnaduwage D; Mulligan AM; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2013 Jul; 140(1):195-205. PubMed ID: 23813303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
    Vesuna F; Lisok A; Kimble B; Raman V
    Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
    Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
    Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric segregation of template DNA strands in basal-like human breast cancer cell lines.
    Liu W; Jeganathan G; Amiri S; Morgan KM; Ryan BM; Pine SR
    Mol Cancer; 2013 Nov; 12(1):139. PubMed ID: 24238140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
    DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
    Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells.
    Vieira AF; Ribeiro AS; Dionísio MR; Sousa B; Nobre AR; Albergaria A; Santiago-Gómez A; Mendes N; Gerhard R; Schmitt F; Clarke RB; Paredes J
    Oncotarget; 2014 Feb; 5(3):679-92. PubMed ID: 24553076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
    Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
    J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.